"Alzheimer's is not a life sentence."
GHPHARM was not founded as a business concept.
It was founded to save a life.
The Mother's Diagnosis
Founder Dr. Gil Hong Park's mother was diagnosed with Vascular Dementia. As a molecular biologist, Dr. Park refused to accept the medical consensus that dementia is "irreversible". He dedicated his life to finding a cure, pivoting 40 years of molecular R&D to save his mother.
Pteridium aquilinum
Bracken Fern R&D
The Discovery: Pterosin D
After years of exhaustive R&D, Dr. Park identified Pterosin D — a natural small molecule derived from Pteridium aquilinum — as a first-in-class dual activator of the PKA/PKG pathway.
Natural extraction was once impossibly expensive, requiring an investment of $50 million per kilogram ($50M/kg), which initially rendered it commercially unviable for global therapeutic use.
The Scalability Innovation
Dr. Park successfully developed a world-first mass synthesis platform for Pterosin D, reducing production costs by 1,000x. This transformed a rare compound into a scalable pharmaceutical reality.
Patient Zero: Full Recovery
"After 6 months of treatment, medical records verified that my mother's cognitive levels had returned to the normal range."
*Verified by Korea University Hospital & SCH Hospital Records. Featured in 2024 TV Interview.
"This medicine saved the founder's mother. Now, our mission is to scale this technology to save millions of families worldwide."
View Scientific Evidence